Biomaterials implanted in the body evoke a “Foreign body response” which results in encapsulation of the material in a collagen-rich protein capsule. Fibroblast cells, which produce collagen, mediate this process that leads to biomaterial rejection / device failure in vivo. Surface nanotopography of BMGs can be used to engineer fibroblast-material interactions.